⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLX News
Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman
prnewswire.com
TLX
Securities Fraud Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX) - Levi & Korsinsky Reminds Investors of January 9, 2026
accessnewswire.com
TLX
Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
TLX
TLX LAWSUIT ALERT: Levi & Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors - Lead Plaintiff Deadline January 9, 2026
accessnewswire.com
TLX
Investors Urged to Contact Levi & Korsinsky for Information Before January 9, 2026 - Telix Pharmaceuticals Ltd. (TLX)
accessnewswire.com
TLX
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
TLX
Shareholders that lost money on Telix Pharmaceuticals Ltd.(TLX) should contact The Gross Law Firm about pending Class Action - TLX
prnewswire.com
TLX
Tune Into the SueWallSt Podcast: Telix Pharmaceuticals Ltd. (TLX) Lawsuit Explained
accessnewswire.com
TLX
Join Class Action to Recover Losses from Telix Pharmaceuticals Ltd. (TLX) - Contact Levi & Korsinsky Before January 9, 2026
accessnewswire.com
TLX
TLX DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Telix Pharmaceuticals Limited Investors to Join the Class Action Lawsuit
accessnewswire.com
TLX